Juan Manuel C. P.
- Country
- Spain
- Department
- Ophthalmology
Research Overview
- Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
- Dose-ranging study of FWY003 in geographic atrophy secondary to age-related macular degeneration: randomized, double-masked, placebo-controlled trial in adults
- Evaluation of Ranibizumab Port Delivery System Refill Regimens in Neovascular Age-Related Macular Degeneration: A Phase IIIb Randomized Study
Data & Insights
Has run more than one trial at 149 of 262 partner sites.
Specializations
Age-Related Macular Degeneration
This investigator specializes in various forms of age-related macular degeneration (AMD), with particular focus on both neovascular AMD and geographic atrophy. Their research encompasses innovative treatment approaches including port delivery systems and gene therapy interventions.
- Neovascular AMD Treatment Modalities
- Geographic Atrophy Management
- Sustained Drug Delivery Systems
Advanced therapeutic approaches include complement inhibition and novel drug delivery platforms.
Retinal Conditions
The investigator focuses on treating diabetic macular edema (DME) and exploring new therapeutic delivery methods. Their work includes evaluation of suprachoroidal delivery systems and comparative treatment efficacy studies.
- Diabetic Eye Disease Management
- Novel Drug Delivery Methods
- Retinal Therapeutic Innovation
Research includes assessment of alternative treatment routes and delivery mechanisms.
Orbital and Inflammatory Disorders
The investigator conducts research in thyroid eye disease (TED), exploring novel therapeutic approaches including subcutaneous treatments. Their work encompasses evaluation of biological therapies for orbital inflammatory conditions.
- Thyroid Eye Disease Treatment
- Innovative Biological Therapies
- Orbital Disease Management
Focus includes development of targeted therapeutic approaches for orbital disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.